Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by mooolaaaa on Apr 30, 2016 8:54am

Rona

Rona stock nearly doubled when Lowes bought them
out. So..... There is a chance Cxr can double if sold to the right company. 
I feel a buyout is definitely in the works......
Comment by Lesalpes29 on Apr 30, 2016 9:08am
For lowes it was strategic buy with cdn$ very low. Cxr can be a strategic buy for many ...
Comment by fdfd12 on Apr 30, 2016 10:39am
Yes RONA doubled BUT CXR was $24US at the time of the annoucement and a double is $48US. CXR won't agree to $48US for a takeout price.
Comment by mooolaaaa on Apr 30, 2016 11:55am
How do you know what stock price Cxr will accept? $48 US is a little low but seemingly fair, especially for a company everyone is bashing. I am long Cxr, but it seems the shorts, analysts, even shareholders are criticizing everything about this company. These are the people who make medication that saves lives, short sellers and politicians are trying to destroy the very company that WILL one day ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities